Ligand Pharmaceuticals Incorporated
US ˙ NasdaqGM ˙ US53220K5048

SecurityLGND / Ligand Pharmaceuticals Incorporated
InstitutionPrudential Financial Inc
Latest Disclosed Ownership64,133 shares
Latest Disclosed Value $ 12,804,153
Prudential Financial Inc reports 40.53% increase in ownership of LGND / Ligand Pharmaceuticals Incorporated

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 64,133 shares of Ligand Pharmaceuticals Incorporated (US:LGND) valued at $12,804,153 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 45,636 shares of Ligand Pharmaceuticals Incorporated. This represents a change in shares of 40.53% during the quarter. The current value of the position is $15,032,775 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F IGAND PHARMACEUTICALS COM NEW 53220K504 64,133 18,497 40.53 12,804 48.40 0.0089
2026-02-13 2025-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 45,636 16,609 57.22 8,628 67.83 0.0104
2025-11-13 2025-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 29,027 660 2.33 5,142 59.46 0.0061
2025-08-12 2025-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 28,367 -12,588 -30.74 3,225 -25.13 0.0042
2025-05-13 2025-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 40,955 -62,040 -60.24 4,306 -60.98 0.0061
2025-02-11 2024-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 102,995 1,360 1.34 11,036 8.48 0.0151
2024-11-14 2024-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 101,635 83,715 467.16 10,173 574.09 0.0143
2024-08-13 2024-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 17,920 -14,865 -45.34 1,510 -37.02 0.0023
2024-05-14 2024-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 32,785 13,830 72.96 2,397 77.09 0.0034
2024-02-13 2023-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 18,955 -52,407 -73.44 1,354 -68.36 0.0020
2023-11-13 2023-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 71,362 -5,470 -7.12 4,276 -22.80 0.0067
2023-08-11 2023-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 76,832 61,261 393.43 5,540 383.76 0.0081
2023-05-12 2023-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 15,571 -2,750 -15.01 1,145 -6.38 0.0018
2023-02-14 2022-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 18,321 2,000 12.25 1,224 -12.95 0.0021
2022-11-04 2022-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 16,321 -805 -4.70 1,405 -8.05 0.0024
2022-08-15 2022-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 17,126 -269 -1.55 1,528 -21.88 0.0024
2022-05-13 2022-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 17,395 -290 -1.64 1,956 -29.77 0.0026
2022-02-14 2021-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 17,685 -340 -1.89 2,785 6.79 0.0035
2021-11-15 2021-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 18,025 6,068 50.75 2,608 66.22 0.0036
2021-08-16 2021-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 11,957 -13,397 -52.84 1,569 -59.40 0.0022
2021-05-12 2021-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 25,354 -73,148 -74.26 3,865 -60.54 0.0058
2021-08-16 2020-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 0099 53220K504 98,502 98,424 126,184.62 9,795 139,828.57 0.0165
2021-02-16 2020-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 98,502 98,424 9,795 0.0165
2021-08-05 2020-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 78 -41 -34.45 7 -46.15 0.0010
2020-11-16 2020-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 94,620 94,501 9,019 0.0170
2021-08-05 2020-06-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 0111 53220K504 119 115 2,875.00 13 0.0024
2020-08-12 2020-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 44,576 44,572 4,986 0.0096
2021-08-05 2020-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 0072 53220K504 4 -48 -92.31 0 -100.00
2020-05-12 2020-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 12,720 12,668 925 0.0020
2021-08-05 2019-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 0104 53220K504 52 16 44.44 5 25.00 0.0013
2020-02-11 2019-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 13,785 13,749 1,438 0.0021
2021-08-05 2019-09-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 0099 53220K504 36 -117 -76.47 4 -76.47 0.0013
2019-11-13 2019-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 19,790 19,637 1,970 0.0031
2021-08-05 2019-06-30 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 153 31 25.41 17 13.33 0.0059
2019-08-08 2019-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 20,235 20,113 2,310 0.0036
2021-08-05 2019-03-31 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 122 44 56.41 15 36.36 0.0064
2019-05-15 2019-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 20,755 20,677 2,609 0.0043
2021-08-05 2018-12-31 13F/A-1 LIGAND PHARMACEUTICALS COM NEW 53220K504 78 -106,798 -99.93 11 -99.96 0.0089
2019-02-07 2018-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 21,346 -85,530 2,897 0.0051
2018-11-07 2018-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 106,876 27,960 35.43 29,336 79.44 0.0432
2018-08-13 2018-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 78,916 1,266 1.63 16,349 27.48 0.0244
2018-05-04 2018-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 77,650 -1,235 -1.57 12,825 18.73 0.0195
2018-02-13 2017-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 78,885 6,735 9.33 10,802 9.97 0.0147
2017-11-02 2017-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 72,150 23,643 48.74 9,823 66.80 0.0162
2017-08-07 2017-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 48,507 -11,158 -18.70 5,889 -6.75 0.0088
2017-05-10 2017-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 59,665 -7,083 -10.61 6,315 -6.89 0.0098
2017-02-07 2016-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 66,748 -6,702 -9.12 6,782 -9.53 0.0109
2016-11-04 2016-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 73,450 -20,450 -21.78 7,496 -33.07 0.0124
2016-08-09 2016-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 93,900 6,703 7.69 11,199 19.93 0.0188
2016-05-09 2016-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 87,197 2,765 3.27 9,338 2.01 0.0167
2016-02-12 2015-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 84,432 -9,730 -10.33 9,154 13.50 0.0166
2015-11-10 2015-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 94,162 -6,870 -6.80 8,065 -20.88 0.0159
2015-08-06 2015-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 101,032 -19,660 -16.29 10,194 9.53 0.0181
2015-05-01 2015-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 120,692 -74,360 -38.12 9,307 -10.33 0.0161
2015-02-06 2014-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 195,052 -71,200 -26.74 10,379 -17.04 0.0188
2014-11-12 2014-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 266,252 25,176 10.44 12,511 -16.69 0.0235
2014-08-13 2014-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 241,076 9,814 4.24 15,017 -3.46 0.0265
2014-05-14 2014-03-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 231,262 -35,900 -13.44 15,555 10.69 0.0290
2014-02-11 2013-12-31 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 267,162 87,860 49.00 14,053 81.10 0.0279
2013-11-07 2013-09-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 179,302 39,300 28.07 7,760 48.12 0.0165
2013-08-07 2013-06-30 13F LIGAND PHARMACEUTICALS COM NEW 53220K504 140,002 140,002 5,239 0.0116
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.